Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $148.32 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $44.81 | 3 | $0 (2024) |
| ABBVIE INC. | $44.26 | 3 | $0 (2024) |
| Novo Nordisk Inc | $30.33 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $15.13 | 1 | $0 (2024) |
| PFIZER INC. | $13.79 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.12 | 5 | Amgen Inc. ($31.02) |
| 2023 | $57.57 | 4 | Novo Nordisk Inc ($16.83) |
| 2021 | $14.63 | 1 | AbbVie Inc. ($14.63) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Inflammation | ||||||
| 10/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 06/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Bone Health | ||||||
| 03/29/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/19/2021 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 17 | $2,533 | $1,003 |
| 2022 | 1 | 15 | 16 | $2,128 | $650.19 |
| 2021 | 3 | 44 | 65 | $8,603 | $3,728 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 17 | $2,533 | $1,003 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 16 | $2,128 | $650.19 | 30.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 28 | $3,780 | $1,527 | 40.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 23 | $3,059 | $1,473 | 48.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 12 | 14 | $1,764 | $728.42 | 41.3% |
About Anna Dagg
Anna Dagg is a Family Medicine healthcare provider based in Great Bend, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2018. The National Provider Identifier (NPI) number assigned to this provider is 1215421094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Dagg has received a total of $148.32 in payments from pharmaceutical and medical device companies, with $76.12 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($148.32).
As a Medicare-enrolled provider, Dagg has provided services to 71 Medicare beneficiaries, totaling 98 services with total Medicare billing of $5,382. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Great Bend, KS
- Active Since 06/15/2018
- Last Updated 08/10/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215421094
Products in Payments
- Otezla (Drug) $31.02
- Rybelsus (Drug) $30.33
- QULIPTA (Drug) $16.47
- ENTRESTO (Drug) $15.13
- LO LOESTRIN FE (Drug) $14.63
- ELIQUIS (Drug) $13.79
- EVENITY (Biological) $13.79
- UBRELVY (Drug) $13.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Great Bend
Perry Smith, M.d, M.D
Family Medicine — Payments: $805.53
Jeffrey Brozek, M.d, M.D
Family Medicine — Payments: $482.67
Dr. Jonathan Pike, M.d, M.D
Family Medicine — Payments: $480.69
Brenda Dinges, Aprn Fnp-C, APRN FNP-C
Family Medicine — Payments: $143.07
Teri Turkle-Huslig, M.d, M.D
Family Medicine — Payments: $123.74
Micca Schneider, Md, MD
Family Medicine — Payments: $116.25